![]() |
|
|
SF Liu, DG McCormack, TW Evans and PJ Barnes
Department of Thoracic Medicine, National Heart and Lung Institute, London, England.
To characterize P2-purinoceptors in pulmonary vessels we have examined the effects of ATP analogs on rat isolated pulmonary artery and vein in vitro. The rank order of potency for causing vasoconstriction was: alpha,beta-methylene-ATP (alpha,beta-meATP) greater than beta,gamma- methylene-ATP (beta,gamma-meATP) greater than 2-methylthio-ATP (2m.S.ATP) greater than ATP for arteries; and alpha,beta-meATP much greater than beta,gamma-meATP = 2m.S.ATP greater than ATP for veins, indicating that a P2x receptor was involved. The contractile response to these analogs was virtually abolished after desensitization of P2x- receptors by alpha,beta-meATP. Removal of the endothelial cells enhanced the contractile responses to all of the ATP analogs in both arteries and veins. The rank order of potency for vasodilatation was 2m.S.ATP much greater than ATP = beta,gamma-meATP much greater than alpha,beta-meATP for arteries and 2m.S.ATP much greater than ATP = beta- gamma-meATP, with alpha,beta-meATP being no effect for veins, indicating a P2y receptor. Pretreatment of the pulmonary arteries with the P2y-antagonist reactive blue 2 caused a rightward shift of the dose- response curves to 2m.S.ATP, ATP and beta,gamma-meATP. Reactive blue 2 was only used with the pulmonary arteries. Removal of the endothelium converted the relaxant responses to all the ATP analogs (except to ATP in pulmonary artery) to further contraction. In the pulmonary artery, the small endothelium-independent relaxation induced by ATP was abolished completely by pretreating the vessels with 100 microM theophylline (a P1-purinoceptor antagonist), suggesting that it was due to conversion of ATP to adenosine.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
Y. Gui, M. P. Walsh, V. Jankowski, J. Jankowski, and X.-L. Zheng Up4A stimulates endothelium-independent contraction of isolated rat pulmonary artery Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L733 - L738. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Olearczyk, A. H. Stephenson, A. J. Lonigro, and R. S. Sprague Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release from erythrocytes Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H940 - H945. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Sprague, J. J. Olearczyk, D. M. Spence, A. H. Stephenson, R. W. Sprung, and A. J. Lonigro Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H693 - H700. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ishiguchi, T. Takahashi, H. Itoh, and C. Owyang Nitrergic and purinergic regulation of the rat pylorus Am J Physiol Gastrointest Liver Physiol, October 1, 2000; 279(4): G740 - G747. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Hakim, L. Ferrario, J. C. Freedman, R. E. Carlin, and E. M. Camporesi Segmental pulmonary vascular responses to ATP in rat lungs: role of nitric oxide J Appl Physiol, March 1, 1997; 82(3): 852 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Hartley and R. Z. Kozlowski Electrophysiological Consequences of Purinergic Receptor Stimulation in Isolated Rat Pulmonary Arterial Myocytes Circ. Res., February 1, 1997; 80(2): 170 - 178. [Abstract] [Full Text] |
||||